Among the types of BC, estrogen receptor-negative [ER(−)] triple negative/basal like (TNBC) BC is the most aggressive type, posing the highest threat to BC patients due to poor prognosis and a lack of targeted therapy2. The gene discussed is ESR1; the disease is breast cancer.